Liverpool, NY, United States of America

Mariano V Ruggeri


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1982-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mariano V Ruggeri: Innovator in Antibiotic Development

Introduction

Mariano V Ruggeri is a notable inventor based in Liverpool, NY (US). He has made significant contributions to the field of antibiotic development, holding two patents that showcase his innovative approaches. His work focuses on improving processes for the preparation of aminoglycoside antibiotics, which are crucial in combating bacterial infections.

Latest Patents

Ruggeri's latest patents include the "Preparation of 1-N-ω-amino-α-hydroxyalkanoyl!kanamycin" and the "Preparation of 1-N-[ω-amino-α-hydroxyalkanoyl]aminoglycoside." The first patent describes an improved process for acylating a polysilylated kanamycin in a substantially anhydrous organic solvent with an acylating derivative of an ω-amino-α-hydroxyalkanoic acid. The second patent outlines a similar process for aminoglycoside antibiotics, emphasizing the importance of these advancements in antibiotic formulation.

Career Highlights

Ruggeri has established a successful career at Bristol-Myers Company, where he has been instrumental in developing new antibiotic formulations. His innovative techniques have contributed to the enhancement of existing antibiotics, making them more effective against resistant bacterial strains.

Collaborations

Throughout his career, Ruggeri has collaborated with esteemed colleagues such as Martin J Cron and John G Keil. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in antibiotic research.

Conclusion

Mariano V Ruggeri's contributions to antibiotic development through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact the medical community by improving the efficacy of essential antibiotics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…